---
schema_version: "secwatch.filing_event.v1"
accession: "0001055726-25-000045"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2025-05-22T23:59:59+00:00"
generated_at: "2026-05-20T17:19:27.282772+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Inovio shareholders elect eight directors, ratify auditor, approve executive compensation and equity plan

## Summary
- Eight directors elected: each received 7.3M-8.4M votes for, 0.6M-1.7M withheld, 11M broker non-votes.
- Ernst & Young ratified as auditor for FY2025: 19.3M for, 0.6M against, 0.2M abstain.
- Advisory say-on-pay passed: 7.9M for, 1.1M against, 0.2M abstain, 11M broker non-votes.
- Amendment and restatement of 2023 Omnibus Incentive Plan approved: 7.8M for, 1.2M against, 0.1M abstain.

## SEC filing metadata
- accession: 0001055726-25-000045
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2025-05-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000105572625000045/0001055726-25-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000105572625000045/ino-20250520.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001055726-25-000045
- JSON: https://secwatch.observer/filing/0001055726-25-000045.json
- Plain text: https://secwatch.observer/filing/0001055726-25-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.